- Home
- PRTS vs INMB Comparison
PRTS vs INMB Comparison
Compare PRTS & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTS | INMB |
|---|---|---|
| Founded | 1995 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.7M | 57.9M |
| IPO Year | 2006 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PRTS | INMB |
|---|---|---|
| Price | $6.30 | $2.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $0.50 | ★ $5.40 |
| AVG Volume (30 Days) | 22.3K | ★ 354.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.25 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.37 | $1.09 |
| 52 Week High | $7.27 | $2.58 |
Technical Indicators
Market Signals| Indicator | PRTS | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 58.57 | 65.83 |
| Support Level | $5.91 | $1.37 |
| Resistance Level | $6.61 | $2.17 |
| Average True Range (ATR) | 0.38 | 0.12 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 69.46 | 88.89 |
Price Performance
Historical ComparisonAbout PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. Its products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.